Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,669.83
1,375.80
1,115.23
923.06
786.47
687.24
610.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,669.83
1,375.80
1,115.23
923.06
786.47
687.24
610.83
Raw Material Cost
571.36
464.78
424.31
352.37
266.75
225.22
194.92
Purchase of Finished goods
7.94
7.02
5.21
10.66
3.08
0.71
14.54
(Increase) / Decrease In Stocks
-24.61
10.80
-23.65
-14.95
-7.60
-8.88
-0.80
Employee Cost
301.53
245.91
202.75
163.62
141.76
138.76
116.61
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.01
-0.01
0.00
0.00
0.00
Selling and Distribution Expenses
24.57
19.44
17.80
18.77
13.14
11.94
10.15
Other Expenses
336.20
270.10
223.41
179.50
154.98
155.53
145.96
Total Expenditure (Excl Depreciation)
1,216.99
1,018.06
849.84
709.96
572.11
523.28
481.38
Operating Profit (PBDIT) excl Other Income
452.84
357.74
265.39
213.10
214.36
163.96
129.45
Other Income
89.13
58.75
36.19
37.90
18.42
18.46
18.27
Operating Profit (PBDIT)
541.97
416.49
301.58
251.00
232.78
182.42
147.72
Interest
12.00
11.30
8.84
4.25
8.51
18.31
11.75
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
529.97
405.19
292.74
246.75
224.27
164.11
135.97
Depreciation
82.64
63.44
57.17
53.95
47.52
40.53
37.29
Profit Before Tax
447.34
341.74
235.56
192.79
176.74
123.58
98.67
Tax
113.96
86.01
58.21
48.74
44.18
29.85
34.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
333.38
255.73
177.35
144.06
132.56
93.74
64.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
333.38
255.73
177.35
144.06
132.56
93.74
64.00
Share in Profit of Associates
5.18
2.53
1.93
2.45
3.31
2.14
1.40
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
338.56
258.26
179.28
146.51
135.87
95.88
65.40
Equity Capital
50.66
47.99
47.97
47.95
47.94
44.12
44.12
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
2,715.00
1,422.07
1,193.65
1,039.53
917.63
390.70
337.25
Earnings per share (EPS)
33.41
26.91
18.69
15.28
14.17
10.87
7.41
Diluted Earnings per share
34.13
26.92
18.67
15.27
15.24
10.86
7.41
Operating Profit Margin (Excl OI)
27.12%
26.0%
23.8%
23.09%
27.26%
23.86%
21.19%
Gross Profit Margin
31.74%
29.45%
26.25%
26.73%
28.52%
23.88%
22.26%
PAT Margin
20.28%
18.77%
16.08%
15.87%
17.28%
13.95%
10.71%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 21.37% vs 23.36% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 31.09% vs 44.05% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 26.58% vs 34.80% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 6.19% vs 27.83% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Poly Medicure With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
1,669.83
2,461.40
-791.57
-32.16%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,669.83
2,461.40
-791.57
-32.16%
Raw Material Cost
571.36
481.50
89.86
18.66%
Purchase of Finished goods
7.94
0.00
7.94
(Increase) / Decrease In Stocks
-24.61
0.00
-24.61
Employee Cost
301.53
482.40
-180.87
-37.49%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
24.57
341.70
-317.13
-92.81%
Other Expenses
336.20
460.30
-124.10
-26.96%
Total Expenditure (Excl Depreciation)
1,216.99
1,765.90
-548.91
-31.08%
Operating Profit (PBDIT) excl Other Income
452.84
695.50
-242.66
-34.89%
Other Income
89.13
93.40
-4.27
-4.57%
Operating Profit (PBDIT)
541.97
788.90
-246.93
-31.30%
Interest
12.00
22.30
-10.30
-46.19%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
529.97
766.60
-236.63
-30.87%
Depreciation
82.64
141.90
-59.26
-41.76%
Profit Before Tax
447.34
624.70
-177.36
-28.39%
Tax
113.96
132.50
-18.54
-13.99%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
333.38
492.20
-158.82
-32.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
333.38
492.20
-158.82
-32.27%
Share in Profit of Associates
5.18
0.00
5.18
Minority Interest
0.00
-5.10
5.10
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
338.56
487.10
-148.54
-30.49%
Equity Capital
50.66
83.60
-32.94
-39.40%
Face Value
5.00
10.00
0.00
Reserves
2,715.00
2,089.10
625.90
29.96%
Earnings per share (EPS)
33.41
58.27
-24.86
-42.66%
Diluted Earnings per share
34.13
58.40
-24.27
-41.56%
Operating Profit Margin (Excl OI)
27.12%
28.26%
0.00
-1.14%
Gross Profit Margin
31.74%
31.14%
0.00
0.60%
PAT Margin
20.28%
20.00%
0.00
0.28%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,669.83 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.37% vs 23.36% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 338.56 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 31.09% vs 44.05% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 452.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 26.58% vs 34.80% in Mar 2024
Annual - Interest
Interest 12.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.19% vs 27.83% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.12%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






